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Introduction: The aim of this study was to describe and compare the changes in ventilator management and
complications over time, as well as variables associated with 28-day hospital mortality in patients receiving mechanical
ventilation (MV) after cardiac arrest.
Methods: We performed a secondary analysis of three prospective, observational multicenter studies conducted
in 1998, 2004 and 2010 in 927 ICUs from 40 countries. We screened 18,302 patients receiving MV for more than
12 hours during a one-month-period. We included 812 patients receiving MV after cardiac arrest. We collected data on
demographics, daily ventilator settings, complications during ventilation and outcomes. Multivariate logistic regression
analysis was performed to calculate odds ratios, determining which variables within 24 hours of hospital admission
were associated with 28-day hospital mortality and occurrence of acute respiratory distress syndrome (ARDS) and
pneumonia acquired during ICU stay at 48 hours after admission.
Results: Among 812 patients, 100 were included from 1998, 239 from 2004 and 473 from 2010. Ventilatory management
changed over time, with decreased tidal volumes (VT) (1998: mean 8.9 (standard deviation (SD) 2) ml/kg actual
body weight (ABW), 2010: 6.7 (SD 2) ml/kg ABW; 2004: 9 (SD 2.3) ml/kg predicted body weight (PBW), 2010:
7.95 (SD 1.7) ml/kg PBW) and increased positive end-expiratory pressure (PEEP) (1998: mean 3.5 (SD 3), 2010: 6.5 (SD 3);
P <0.001). Patients included from 2010 had more sepsis, cardiovascular dysfunction and neurological failure, but
28-day hospital mortality was similar over time (52% in 1998, 57% in 2004 and 52% in 2010). Variables independently
associated with 28-day hospital mortality were: older age, PaO2 <60 mmHg, cardiovascular dysfunction and less use
of sedative agents. Higher VT, and plateau pressure with lower PEEP were associated with occurrence of ARDS and
pneumonia acquired during ICU stay.
Conclusions: Protective mechanical ventilation with lower VT and higher PEEP is more commonly used after
cardiac arrest. The incidence of pulmonary complications decreased, while other non-respiratory organ failures
increased with time. The application of protective mechanical ventilation and the prevention of single and multiple
organ failure may be considered to improve outcome in patients after cardiac arrest.* Correspondence: ppelosi@hotmail.com
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Many studies in patients after cardiac arrest with return
of spontaneous circulation (ROSC) focus on how to im-
prove survival and neurological outcomes. Despite several
interventions, such as targeted temperature management
[1-4], vasopressor drugs [5], control of seizures and blood
sugar level [6], poor neurological outcome and mortality
are still as high as 50% [4,7,8].
However, other organ failures should be considered in
addition to neurological damage. Roberts et al. reported
that the highest cardiovascular- and respiratory-specific
Sequential Organ Failure Assessment (SOFA) scores
are associated with higher in-hospital mortality in 203
post-cardiac arrest patients [9], suggesting the value of
hemodynamic and respiratory optimization. A recent study
demonstrated that the outcomes of mechanically ventilated
patients have improved over time [10]. The characteristics
and the influence of ventilator settings, that is, tidal volume
and positive end-expiratory pressure (PEEP), on organ
failure and outcome of patients after cardiac arrest have
not been previously described.
The main aim of this study was to describe and compare
the changes in ventilator management and complications
over time. Secondary objectives were to investigate the po-
tential risk factors associated with 28-day hospital mortal-
ity and development of pulmonary complications, namely
acute respiratory distress syndrome (ARDS) and pneumo-
nia acquired during intensive care unit (ICU) stay, in pa-
tients without pre-existing lung injury at ICU admission.
Methods
Study design
We performed a secondary analysis of three prospective
observational cohort studies conducted in 1998 [11],
2004 [12] and 2010 [10] on adult patients (≥18-years-
old) who received mechanical ventilation for more than
12 hours, and was performed in a total of 927 ICUs in
40 countries. National coordinators recruited local investi-
gators from eligible ICUs (see Additional file 1). In order
to minimize practice changes in response to observation,
only the investigator and research coordinators at each
site were aware of the exact purpose and timing of the
study. The research ethics board of each participating
institution approved the protocol and need for informed
consent was according to local rules [10-12]. Please see
Additional file 1 for details of each participant institution.
Protocol and data collection
From the 18,302 patients enrolled, we included 812 pa-
tients (4.4%) who received mechanical ventilation after
ROSC post-cardiac arrest for the purpose of this ana-
lysis. The eligible patients were those receiving mechan-
ical ventilation caused by developing sudden cessation of
cardiopulmonary function.We collected data on baseline characteristics and blood
gas measurements at ICU admission, daily ventilator set-
tings, clinical management, and blood gas measurements,
characteristics and observed complications while patients
were ventilated or up to day 28. We also collected data on
ICU, in-hospital and 28-day mortality and length of stay
outcomes. Detailed descriptions of the variables collected,
along with their definitions have previously been pub-
lished [10-12]. In brief, complications arising during the
course of the mechanical ventilation was defined as ARDS,
pneumonia, sepsis and/or multiorgan failure (cardiovascu-
lar, respiratory, renal, hepatic and hematologic, defined as
a score higher than two points on the SOFA scale. Pneu-
monia acquired during ICU stay was defined by modifying
Centers for Disease Control and Prevention criteria which
require the presence of a new radiographic infiltrate per-
sistent for 48 hours or more plus a body temperature of
more than 38.5°C or less than 35.0°C, a leukocyte count of
more than 10,000/μL or less than 3,000/μL, purulent
sputum or change in character of sputum, or isolation of
pathogenic bacteria from an endotracheal aspirate [11].
In the 1998 cohort, data on height and Glasgow Coma
Score (GCS) were not collected; therefore no data re-
garding tidal volume/kg predicted body weight (PBW)
were available in that group. The use of neuromuscular
blocking agents, sedatives and analgesic drugs was re-
corded daily for 28 days when the drugs were given daily
for three or more hours. The onset of weaning was the
time point when the physician considered the patient
ready for spontaneous ventilation. Weaning was catego-
rized as a trial of spontaneous breathing and gradual re-
duction in the level of ventilator support. We recorded
date of extubation, date of any reintubation and tracheos-
tomy, if and when performed. Patients were prospectively
followed until hospital discharge.
Statistical analysis
Data are expressed as mean (standard deviation), median
(interquartile range) and absolute and relative frequencies,
as appropriate. One-way analysis of variance (ANOVA)
were used to compare continuous variables, and chi-square
tests were used for categorical variables. We rejected the
null hypothesis of no difference among cohorts at a nom-
inal significance level of 0.05.
Multivariate logistic regression analysis (backward step-
wise) was performed to calculate odds ratios determining
which variables within 24 hours of hospital admission
were associated with 28-day hospital mortality. The vari-
ables with a P value less than 0.1 in univariate analysis
were included in multivariate analysis. Variables consid-
ered for inclusion in multivariate analysis associated with
28-day mortality were age, PaO2, arterial pH (pHa), use of
sedative agents, cardiovascular dysfunction and renal
failure during the first 24 hours of mechanical ventilation.
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the following: pHa <7.35, pHa 7.35 to 7.45 and pHa >7.45,
according to the normal pHa range, which is 7.35 to 7.45.
PaO2 was categorized as the following: PaO2 <60 mmHg,
PaO2 60 to 300 mmHg and PaO2 ≥300 mmHg, according
to recent publications which demonstrated that PaO2 <60
mmHg and PaO2 ≥300 mmHg were independently asso-
ciated with in-hospital mortality [13-15]. We did not
include GCS in the multivariate analysis because during
mechanical ventilation with sedation, the GCS is unreliable.
In addition, GCS data was not collected in 1998. Odds ratios
with 95% confidence intervals were calculated for statistically
significant variables to determine independent predictors of
mortality. These analyses were performed using SPSS
version 16.0, SPSS for Windows, SPSS Inc., Chicago, USA.
The development of pulmonary complications, namely
ARDS and pneumonia acquired during ICU stay, in pa-
tients without pre-existing lung injury at ICU admission
were collected. We also performed multivariate logistic
regression analysis to determine which variables within
24 hours of hospital admission were associated with theTable 1 Baseline characteristics and management during mec
Cohort 1998
(N = 100)
Age, years, mean (SD) 66 (14)
Female, n (%) 37 (37)
Body mass index, kg/cm2, mean (SD) na
SAPS II, points, mean (SD) 61 (19)
Glasgow Coma Score at admission, median (IQR) na
Arterial blood gases at admission
pHa, mean (SD) 7.17 (0.09)
PaCO2, mmHg, mean (SD) 50 (13)
Ratio PaO2 to FiO2, mmHg, mean (SD) 249 (78)
Ventilatory settings during mechanical ventilation
Tidal volume, ml/kg ABW, mean (SD) 8.9 (2)
Tidal volume/kg PBW mean (SD) na
Respiratory rate, bpm, mean (SD) 17 (4)
PEEP, cmH2O, mean (SD) 3.5 (3)
Peak pressure, cmH2O, mean (SD) 29.1 (7.5)
Plateau pressure, cmH2O, mean (SD) 22.7 (3.7)
PaCO2, , mmHg, mean (SD) 37.3 (7.4)
pHa, mean (SD) 7.41 (0.08)
Ratio PaO2 to FiO2, mmHg, mean (SD) 238 (95)
Sedation, n (%) 50 (50)
Analgesia, n (%) 20 (20)
Neuromuscular blocking, n (%) 8 (8)
ABW, actual body weight; IQR, interquartile range; na, no data available, PCV, Pressu
pH; SAPS, Simplified Acute Physiology Score; SD, standard deviation.occurrence of ARDS and pneumonia acquired during
ICU stay at 48 hours after admission. We excluded pa-
tients with diagnosed ARDS at admission. The variables
considered for inclusion in the analysis were age, pHa,
plateau pressure, PaO2 and sepsis during the first 24 hours
of hospital admission.
Results
Characteristics of included patients and management
during mechanical ventilation
In Table 1, baseline characteristics between the three
cohorts are shown. Baseline characteristics including
age, body mass index, gender and Simplified Acute Physi-
ology Score (SAPS) were not different across the cohort
time periods. At admission, the most significant difference
was the lower GCS in patients included in 2010 versus
patients included in 2004 (in 1998 this variable was not
registered).
As shown in Figure 1, the mode of mechanical ventila-
tion, expressed as days of use per 1,000 days of invasive
mechanical ventilation, changed over time with a significanthanical ventilation of included patients
Cohort 2004 Cohort 2010 P
(N = 239) (N = 473)
63 (16) 63 (16) 0.261
90 (38) 174 (37) 0.966
27 (8) 27 (7) 0.754
56 (20) 59 (20) 0.060
6 (3-15) 3 (3-8) <0.001
7.23 (0.20) 7.23 (0.18) 0.003
48 (22) 50 (23) 0.733
233 (116) 221 (186) 0.367
7.4 (2) 6.7 (2) <0.001
9.04 (2.3) 7.95 (1.7) <0.001
18 (6) 19 (6) <0.001
4.8 (4) 6.5 (3) <0.001
27.1 (7.9) 24.1 (7.9) <0.001
21.5 (6.5) 19.5 (6.3) <0.001
38.8 (10.4) 39.8 (11.7) <0.001
7.39 (0.1) 7.39 (0.1) <0.001
242 (95) 252 (114) <0.05
175 (73) 332 (70) <0.001
na 272 (58) <0.001
29 (12) 99 (21) <0.001
re controlled ventilation; PEEP, Positive end-expiratory pressure; pHa, arterial
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Figure 1 Mode of ventilation and days of use per 1,000 days of invasive mechanical ventilation from 1998, 2004 and 2010. Days during weaning from
mechanical ventilation process are excluded (light gray square symbol = 1998, black square symbol = 2004 and dark gray square symbol = 2010)*.
SIMV, synchronized intermittent mandatory ventilation; SIMV_PS, synchronized intermittent mandatory ventilation with pressure support; PSV, pressure
support ventilation; PCV, pressure control ventilation; PRVC, pressure regulated volume control ventilation; APRV, airway pressure release ventilation;
BIPAP, biphasic positive airway pressure. *Among three years, days of use per 1,000 days of invasive mechanical ventilation in each mode of ventilation
are statistically significant difference (P <0.001).
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regulated volume control (PRVC), and a significant de-
crease of other considered modes. Among ventilation set-
tings over the years we found a significant reduction in
tidal volume, peak and plateau pressure, and a significant
increase of respiratory rate, PEEP and PaCO2. Sedation,
analgesia and neuromuscular blocking were frequently used
in 2010 (Table 1). At 24 hours after ICU admission, in pa-
tients with ARDS compared to those without ARDS at ICU
admission, tidal volume and respiratory rate were similar
(7.3 (standard deviation (SD) 1.8) ml/kg actual body weight
(ABW) versus 7.5 (SD 2) ml/kg ABW, P = 0.613,
and 18.1 (SD 5.9) rate/min versus 17.7 (SD 5.5) rate/Table 2 Comparison of complications emerged over the cours
Cohort 1998
(N = 100)
Acute respiratory distress syndrome, n (%) 4 (4)
Acquired intensive care unit pneumonia, n (%) 13 (13)
Sepsis, n (%) 3 (3)
Barotrauma, n (%) 2 (2)
Cardiovascular failure, n (%) 25 (25)
Renal failure, n (%) 20 (20)
Hepatic failure, n (%) 2 (2)
Hematological failure, n (%) 11 (11)
Neurological failurea
Glasgow coma scale, median (IQR)
na
aLowest Glasgow Coma Scale during the ventilatory support.
na, no data available; IQR, interquartile range.min, P = 0.658), while applied PEEP was higher (7.3
(SD 4.5) cmH2O versus 5.2 (SD 3.1) cmH2O, P =
0.000).These results mentioned overall patients (includ-
ing 1998, 2004 and 2010).Complications during mechanical ventilation
As shown in Table 2, the incidence of pneumonia ac-
quired during ICU stay decreased from 13% in 1998 to
4% in 2010 (P = 0.001). In the meantime, other non-
respiratory organ failures like sepsis, cardiovascular
dysfunction, neurological and hepatic failure signifi-
cantly increased.e of mechanical ventilation
Cohort 2004 Cohort 2010 P
(N = 239) (N = 473)
7 (3) 31 (7) 0.102
14 (6) 18 (4) 0.001
6 (6.5) 89 (19) <0.001
6 (3) 7 (2) 0.62
46 (19) 229 (48) <0.001
60 (25) 140 (30) 0.104
30 (13) 24 (5) <0.001
17 (7) 31 (7) 0.296
4 (3-10) 3 (3–6) <0.001
Table 3 Comparison of variables related to weaning process
Cohort 1998 Cohort 2004 Cohort 2010 P
(N = 100) (N = 239) (N = 473)
Accidental extubation, n (%)a 3 (3) 6 (3) 29 (6) 0.062
Reintubation, % 67 33 14 0.074
Patients weaned and scheduled extubated, n (%) 47 (47) 104 (44) 211 (45) 0.856
Method for first attempt
Spontaneous breathing trial, n (%) 33/47 (70) 71/104 (68) 154/211(73) 0.675
T-piece, % 48.5 38 36 0.022
CPAP, % 6 34 24
Low level pressure support, % 42 27 40
Other, % 3 1 0
Gradual reduction of support, n (%) 14/47 (30) 33/104 (32) 57/211 (27) 0.675
Pressure support, % 14 61 89 <0.001
SIMV, % 29 6 0
SIMV-PS, % 50 18 9
Other, % 7 15 2
Failure of first weaning attempt, n (%) 24/47 (51) 45/104 (43) 95/211 (45) 0.667
Method for second attempt
Spontaneous breathing trial, n (%) 21 (87.5) 10 (22) 59 (62) <0.001
T-piece, % 67 40 36 0.049
CPAP, % 5 20 34
Low level pressure support, % 24 40 30
Other, % 5 0 0
Gradual reduction of support, n (%) 3 (12.5) 35 (78) 36 (38) <0.001
Pressure support, % 0 66 94 <0.001
SIMV, % 0 6 0
SIMV-PS, % 100 14 3
Other, % 0 14 3
Reintubation after scheduled extubation, % 11 7 11 0.426
Tracheotomy, n (%)a 12 (12) 30 (13) 66 (14.5) 0.758
aExcluded patients with prior tracheostomy: 1 patient in 1998, 7 patients in 2004 and 18 patients in 2010.
SIMV, synchronized intermittent mandatory ventilation; SIMV-PS, synchronized intermittent mandatory ventilation with pressure support; PSV, pressure support
ventilation; CPAP, continuous positive airway pressure.
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Table 3 demonstrates the characteristics of variables
related to the weaning process across the three cohort
time periods. The percentage of patients who were
weaned and extubated was similar over time (47% in
1998, 44% in 2004 and 45% in 2010; P = 0.856). Among
weaning methods, spontaneous breathing trial was more
commonly used than gradual reduction of ventilator
support. PSV was mostly used among gradual reduction
of support methods, and its use tended to increase
(12.5% in 1998, 78% in 2004 and 38% in 2010). In the
spontaneous breathing trial group, the most common
method was low-level PSV. Tracheostomy was per-
formed in 13.8% of patients overall, and did not change
significantly over time.Outcomes
We observed significant differences in the duration of
ventilatory support over time, with a longer duration of
mechanical ventilation in the most recent study of 2010
(Table 4). There were no differences in length of stay in
the ICU or in the hospital (Table 4).
Factors associated with 28-day hospital mortality
Table 5 shows the univariate and logistic regression analysis
for 28-day hospital mortality of cardiac arrest patients.
In the multivariate analysis, older age, PaO2 <60 mmHg,
less use of sedative drugs and the presence of cardiovascu-
lar dysfunction within 24 hours from hospital admission
were found to be associated with 28-day hospital mortality
(odds ratio 1.01, 95% confidence interval 1.00 to 1.03;
Table 4 Comparison of outcomes
Cohort 1998 Cohort 2004 Cohort 2010 P
(N = 100) (N = 239) (N = 473)
Days of mechanical ventilation, median (IQR)a 4 (3–7) 5 (3–9) 6 (4–10) <0.001
Length of stay in the intensive care unit, days, median (IQR) 7 (3–11) 6 (4–12) 6 (3–12) 0.925
Length of stay in the hospital, days, median (IQR) 14 (7–27) 13 (6–24) 12 (6–26) 0.934
Mortality in the intensive care unit, n (%) 44 (44) 115 (48) 223 (49) 0.785
Mortality at day 28, n (%) 52 (52) 137 (57) 246 (52) 0.384
Mortality in the hospital, n (%) 57 (57) 143 (60) 259 (55) 0.434
aIncluding time devoted to weaning from mechanical ventilation. IQR: interquartile range.
There was no difference in 28-day hospital mortality over time (52% in 1998, 57% in 2004 and 52% in 2010 (Table 4).
Table 5 Univariate and logistic regression analysis for 28-day mortality of cardiac arrest patients
Variable Univariate analysis Odds ratio (95% CI) P Logistic regression Odds ratio (95% CI) P
Age, yearsa 1.02 (1.01–1.03) 0.002 1.01 (1.00–1.03) 0.010
SAPS II score, pointsa 1.03 (1.02–1.03) <0.001
Glasgow Coma Scale, pointsb 0.92 (0.88–0.95) <0.001
PaO2 60–300 mmHg
b 1 (reference) 1 (reference)
PaO2 <60 mmHg 2.23 (1.05–4.72) 0.036 2.71 (1.06–6.95) 0.038
PaO2 ≥300 mmHg 1.19 (0.76–1.85) 0.444 0.89 (0.54–1.46) 0.640
pHa 7.35–7.45b 1 (reference) 1 (reference)
Acidosis (pHa <7.35) 1.48 (1.07–2.04) 0.017 1.40 (0.98–2.02) 0.068
Alkalosis (pHa >7.45) 1.07 (0.67–1.71) 0.770 1.20 (0.71–2.02) 0.491
PaCO2 35–45 mmHgb 1 (reference)
PaCO2 <35 mmHg 1.20 (0.86–1.68) 0.277
PaCO2 >45 mmHg 0.94 (0.70–1.41) 0.973
Tidal Volume/PBWml/kgb
Tidal Volume/PBW 6–8 ml/kg 1 (reference)
Tidal Volume/PBW <6 ml/kg 1.01 (0.51–2.02) 0.975
Tidal Volume/PBW >8 ml/kg 0.76 ( 0.55–1.06) 0.111
PEEP cmH2O
b
PEEP 6–8 cmH2O 1 (reference)
PEEP <6 cmH2O 1.35 (0.94–1.95) 0.100
PEEP >8 cmH20 0.86 (0.52–1.42) 0.556
Pplat cmH2O
b
Pplat 28–30 cmH2O 1 (reference)
Pplat <28 cmH2O 0.58 (0.28–1.22) 0.149
Pplat >30 cmH2O 0.64 (0.22–1.89) 0.421
Use of sedative drugsb 0.61 (0.46–0.81) 0.001 0.51 (0.36–0.72) 0.000
Cardiovascular failure/shock (yes/no)b,c 1.53 (1.15–2.03) <0.001 1.65 (1.17–2.32) 0.004
ARDS (yes/no)b,c 3.14 (1.41–6.97) 0.005
Renal failure (yes/no)b,c 1.35 (0 .95–1.91) 0.095 1.34 (0.91–1.95) 0.135
Hepatic failure (yes/no)b,c 1.20 (0.72–2.00) 0.483
Sepsis (yes/no)b,c 1.38 (0.88–2.18) 0.163
Hematologic failure (yes/no)b,c 1.05 (0.51–2.17) 0.885
SAPS, Simplified Acute Physiology Score; PBW, predicted body weight; ml, milliliters; kg, kilograms PEEP, positive end-expiratory pressure; Pplat, plateau pressure;
pHa, arterial pH; ARDS, acute respiratory distress syndrome; PaO2, partial pressure of oxygen in arterial blood; PaCO2, partial pressure of carbon dioxide in arterial
blood; CI, confidence interval.
aAge and SAPS score were collected as baseline characteristics, bValues within 24 hours from admission, cthe absence of organ failure as the reference value.
Sutherasan et al. Critical Care  (2015) 19:215 Page 6 of 11
Sutherasan et al. Critical Care  (2015) 19:215 Page 7 of 11odds ratio 2.71, 95% confidence interval 1.06 to 6.95;
odds ratio 0.51, 95% confidence interval 0.36 to 0.72; and
odds ratio 1.65, 95% confidence interval 1.17 to 2.32,
respectively).
Factors associated with acute respiratory distress
syndrome and ICU-acquired pneumonia
At multivariate analysis, in patients without lung injury
at admission, the potential risk factor for the develop-
ment of ARDS 48 hours after ICU stay was higher plat-
eau pressure (odds ratio 1.12, 95% confidence interval
1.04 to 1.21), while those associated with ICU pneumo-
nia acquired during ICU stay were higher tidal volume
and lower applied PEEP levels (odds ratio 1.003, 95%
confidence interval 1.0003 to 1.01; and odds ratio 0.89,
95% confidence interval 0.80 to 0.99, respectively).
Discussion
In this large retrospective analysis of prospective obser-
vational cohort, we described the evolution of ventilator
management, and the occurrence of pulmonary and
other non-respiratory organ failure over time. Further-
more, we investigated variables associated with 28-day
hospital mortality and the occurrence of ARDS and/or
pneumonia acquired during ICU stay among cardiac
arrest patients undergoing mechanical ventilation. We
found that: the use of protective and assisted mechanical
ventilation increased from 1998 to 2010; pulmonary
complications decreased, while cardiovascular and
neurological complications, and sepsis increased with
years; independent risk factors for 28-day hospital mor-
tality were older age, PaO2 <60 mmHg, less use of seda-
tive drugs and the presence of cardiovascular dysfunction
at 24 hours after ICU admission; and in patients without
lung injury at ICU admission, higher tidal volume, higher
plateau pressure and lower PEEP in the first 24 hours were
independent potential risk factors for developing ARDS or
pneumonia acquired during ICU stay.
To our knowledge, this is the first study describing
ventilator management in a large sample of patients after
cardiac arrest undergoing mechanical ventilation in ICU.
Our results show that protective mechanical ventilation
is increasingly used among patients after cardiac arrest.
The implementation of protective mechanical ventilation
was associated with a progressive reduction in pneumo-
nia acquired during ICU stay over time, and a lower
incidence of ARDS than that reported in mechanically
ventilated patients [16,17]. Similar changes in ventilation
pattern have recently been shown in a general popula-
tion of critically ill patients, associated with a reduction
of development of ARDS [10,18]. Protective ventilation
with low tidal volume has been shown to be associated
with a reduction in respiratory failure and mortality in
non-ARDS lung patients [19,20], and postoperativecomplications after surgery [21,22]. In donors, protect-
ive mechanical ventilation increased the number of
lungs eligible to be harvested compared to traditional
mechanical ventilation [23]. The application of PEEP
ranging from 5 to 8 cmH2O in non-hypoxemic patients
decreased the incidence of ventilator-associated pneu-
monia [24]. Moreover, protocols aimed to prevent
ventilator-associated pneumonia have been more
widely implemented in recent years [25,26].
On the other hand, we observed an increased incidence
of non-pulmonary organ failure (sepsis, cardiovascular
dysfunction and neurological failure) over time, which
may increase the duration of mechanical ventilation. The
increase in non-pulmonary complications may be ex-
plained by the implementation of targeted temperature
management protocols, or by higher incidence of aspir-
ation, and thus sicker patients [7], which might predispose
to infection and consequent multiple organ failure [27].
The significant differences in the duration of ventilatory
support over time, with a longer duration in the most
recent study of 2010, is probably because of the implemen-
tation of targeted temperature management protocols, and
thus longer sedation.
A previous study demonstrated that changes in mechan-
ical ventilation practice were associated with a significant
decrease in mortality [10]. In post-cardiac arrest patients,
despite the introduction of temperature management, per-
cutaneous coronary intervention and standard operating
procedures, we did not observe any change in mortality
over the years, likely due to the balance between de-
creased pulmonary and increased extra-pulmonary inci-
dence of complication. We also found that the main
independent predictors of 28-day in-hospital mortality
were older age, PaO2 <60 mmHg, use of sedative drug,
and cardiovascular dysfunction within 24 hours from ad-
mission, in line with previous reports [14,15].
In the present study, the analysis by logistic regres-
sion demonstrated that PaO2 <60 mmHg is a predictor of
28-day hospital mortality. This result is different from pre-
vious meta-analysis showing that not only hypoxemia but
also hyperoxemia are associated with higher in-hospital
mortality [28]. The effects of high oxygen tension to in-
crease neuronal damage after cardiac arrest are conflicting
[13,14,29-31]. We also found that higher or lower PaCO2
level had no detectable association with mortality. This
was different from previous studies showing that hypo-
carbia defined by PaCO2 <35 mmHg was associated with
higher in-hospital mortality [28,32], while hypercapnia
defined by PaCO2 >45 mmHg was associated with better
outcome [33,34].
Use of sedative drugs was associated with 28-day mor-
tality in this cohort. This finding is in contrast to other
studies showing that sedation protocols did not affect
mortality in a general population of critically ill patients
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cohort years. The lower GCS on admission in the most
recent cohort would indicate more severe brain injury,
and thus a lower need for sedation and a higher risk of
death. On the other hand, our data suggest that higher
sedation in the early phase after cardiac arrest might
promote less secondary brain injury and better imple-
mentation of protective mechanical ventilation. Further-
more, the use of sedative drugs may be related to the
implementation of therapeutic hypothermia, which was
associated with the improvement of outcome in ROSC
patients [7,8].
In Table 1, 26% (63 out of 239) of the patients in the
2004 study had a GCS of 15. The study population in-
cluded patients who developed cardiac arrest and needed
mechanical ventilation due to sudden and unexpected
cessation of cardiopulmonary functions in any rhythms
(referred to any rhythms that cause cessation of cardio-
pulmonary functions i.e. Pulseless electrical activity, asys-
tole, ventricular fibrillation and ventricular tachycardia);
this is not the population included in target temperature
management studies, therefore we expect that a higher per-
centage of patients awake upon arrival in ICU. Our study is
comparable with the study by Gold et al. [36] on patients
with out-of-hospital cardiac arrest of any rhythm, which
demonstrated that of the 185 survivors, 96 patients (50%)
were sufficiently awake upon arrival to the ICU so they did
not meet the targeted temperature management protocol
inclusion criteria, but data on GCS were not reported.
In our study, we evaluated the potential independent
risk factors for development of pulmonary complications
in patients without pre-existing lung injury at ICU ad-
mission. We found that higher tidal volume and higher
plateau pressure with lower PEEP were associated with
occurrence of lung worsening during ICU stay. These
findings are in line with those reported in patients
without lung injury in the perioperative period [19-22],
and in the ICU [19], showing that protective ventilation
by low tidal volume and plateau pressure <20 cmH2O re-
sulted in a decreased incidence of pulmonary complica-
tions after initiation of mechanical ventilation [19-22,37].
We also found that tidal volume was similar, while PEEP
was slightly higher in patients with ARDS compared to
those without ARDS at ICU admission. This suggests that
protective ventilation should include lower tidal volume
than actually used in daily clinical practice in cardiac
arrest patients with ARDS.
The use of controlled mechanical ventilation de-
creased, while pressure support increased with years.
The use of assisted ventilation may be associated with
potential advantages like the use of less sedative agents
[38-40], better hemodynamic stability [39,40], less atro-
phy of respiratory muscles [41] and ventilator-associated
lung injury [42,43]. The rate of tracheostomy was 12 to14.5% higher than that reported in a general population
of critically ill patients (11%) [12], and comparable to
that reported in neurological patients (13%) [44]. This
might be explained by the possible occurrence of re-
sidual neurological deficits in cardiac arrest patients due
brain hypoxia impairing cough, swallowing and secretion
clearance [45].
Our study has some limitations. First, this was a post-
hoc analysis of previously collected available data, where
the statistically significant predictors of mortality might
have been influenced by undefined confounding factors,
that is, site, cause and initial rhythm of the cardiac
arrest. A statistical post-hoc analysis on 28-day hospital
mortality was performed to assess the power of mortality
variation among the years, and showed a power of
less than 50%, so the variation of mortality over years
should be interpreted with caution. Second, our study
focused on the details related to mechanical ventila-
tion. Thus, we did not record possible implementa-
tion of targeted temperature management, including
the details related to the causes of cardiac arrest [46].
However, a recent study showed that moderate
hypothermia did not affect mortality compared to mild
hypothermia [4]. Third, although the GCS was found to
be associated with 28-day mortality in the univariate ana-
lysis, we did not include GCS in the multivariate analysis.
Since the evaluation of GCS is not reliable within the first
72 hours during mechanical ventilation with sedation, and
data were not collected in 1998. The lower GCS on admis-
sion in the most recent cohort would indicate more severe
brain injury, and thus lower need for sedation and higher
risk of death.
Fourth, we also did not have access to cardiac arrest-
related variables, like whether the arrest was witnessed
or not, whether bystander cardiopulmonary resuscitation
was performed, initial presenting rhythm and the time of
resuscitation commencement or return of spontaneous
circulation. Fifth, in the multivariate logistic regression
analysis defining risk factors associated with 28-day hos-
pital mortality and the development of ARDS and/or
pneumonia acquired in ICU, we used data collected within
24 hours after admission, therefore there were very few
missing data. Nevertheless, we used variables regardless of
the different years, which might have been affected by
the change of clinical management, and the number
of patients with development of ARDS and/or pneumonia
acquired in ICU is a small portion of the whole popu-
lation (5% of the total population). For this reason, the
results of multivariate analysis should be interpreted
with caution.
Conclusions
Protective mechanical ventilation with lower tidal vol-
ume and higher PEEP is more commonly used after
Sutherasan et al. Critical Care  (2015) 19:215 Page 9 of 11cardiac arrest. The incidence of pulmonary complica-
tions decreased, while other non-respiratory organ
failures increased with time. The application of protective
mechanical ventilation and the prevention of single and
multiple organ failure may be considered to improve out-
come in patients after cardiac arrest.
Key messages
 The use of protective mechanical ventilation in
patients after cardiac arrest increased from 1998
to 2010, and is associated with a decrease in
pulmonary complications.
 Variables independently associated with 28-day
in-hospital mortality were: older age, PaO2 <60
mmHg, cardiovascular dysfunction and less use
of sedative agents.
 The application of protective mechanical ventilation
and the prevention of single and multiple organ
failures may be considered to improve outcome in
patients after cardiac arrest.
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